APSAD 2018
Australasian Professional Society on Alcohol and other Drugs


Presentation Types

We welcome you to submit an abstract for the APSAD Auckland 2018 Conference. We are calling for abstracts for the following presentation types;

Presentation Type Time allocated Description
Oral Presentation 10 minutes Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.
Poster Presentation Permanently displayed during the conference.
Authors must be standing with their posters during the dedicated Poster Session
Posters can present research in progress, case studies, divisional projects or clinical topics. A poster viewing session will take place for delegates to discuss the posters with their authors.
*New in 2018* Practice Based/Service Delivery Oral Presentation 10 minutes (Standard Oral Presentation) Oral presentations analysing issues and solutions to problems in clinical practice, community engagement, education, health promotion and policy. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.
Symposium Presentation 60 or 75 minutes.
Suggested timings: 10 minutes for each presentation, 5 minutes for the discussant, and a total of 15 minutes allocated for discussions
Symposia provide an opportunity to present on one topic, often from multiple standpoints, providing a coherent set of papers for discussion.
Workshop Presentation 60 minutes Workshops should facilitate and engage discussion with the participants. Consider the objectives for your participants and the learning outcomes. Lecture-style presentation should be kept to a minimum keeping in mind that a workshop is a facilitation exercise.
Food for Thought Presentation 5 minutes including question time Food for Thought presentations are for case studies, clinical perspectives, new services and consumer viewpoints. These presentations do not require the same rigorous research basis as standard oral presentations, and must be submitted on the Food for Thought template.

For information regarding types of presentations and abstract preparation guidelines please see the abstract guidelines. Abstracts must be submitted by Sunday 13 May 2018.

Abstract Templates

Abstracts must be submitted using the appropriate abstract template, please see the template options below;

Please read the abstract guidelines carefully. Any abstracts that do not conform to the guidelines will not be considered.

The Scientific Advisory Committee may reallocate a presentation type on the basis of time, content, space available and applicability to the Conference themes.

Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.

Disclosure of Interest/Ethical Statement

APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.

For an example of a disclosure of interest/ethical statement please see below

Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study.

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

Selection Criteria

Abstracts will be favoured at review if they incorporate:

  • Completed rather than future work (i.e. final results)
  • Original data of high quality.
  • An analysis that extends existing knowledge
  • Clarity of methodology, analysis and presentation of results
  • Specific rather than general findings

In balancing the program, the committee may require authors to present their work in an alternate format (e.g. as a poster rather than oral presentation).

Note: We encourage abstracts that are based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the Indigenous community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.

Themes for Submission

Authors must select one primary and one secondary theme of the following that their abstract relates to.

Addiction reconceptualised Adolescents / youth Other AOD issues
Aetiology (including genetics) Alcohol Overdose
Blood-borne viruses (incl. STI) Cannabis Over the counter codeine rescheduling
Children & families Coercive treatment Pharmaceuticals (consumption)
Cognitive impairment training Comorbidity Prescription opioid treatment
Consumers & peers Crime, justice & legal issues Prevention & early intervention
Cross culture & international Drug monitoring/novel psychoactive - Prisons & prisoner health
Drug policy reform Ecstasy & emerging psychoactive substances Primary Care - pharmacy in primary care
eHealth – behavioural change Epidemiology Psychopharmacology & psychobiology
First Peoples Gambling Regional challenges & innovations
Harms & harm reduction Health policy & reforms Special populations
Health services & systems Health, law & human rights Social & community issues
Heroin & opioids Injecting drug use Translational research
Innovative prescribing – medicinal cannabis, e-cigs, etc. LGBTIQ Tobacco & Tobacco Cessation
Methamphetamine & psychostimulants Neuroscience Treatment & interventions
Methamphetamine & psychostimulants Older adults Treatment settings
Workforce issues Well at Work Women & maternal issues


Notification of Acceptance

Notifications of acceptance will be sent via e-mail to the submitting author by 16 July 2018. Abstracts submitted for oral will also be considered and reviewed for a poster presentation.

Publication in the Drug and Alcohol Review

Accepted abstracts will be published in a supplement of the Drug and Alcohol Review distributed at the conference.

The Drug and Alcohol Review is APSAD’s official journal and is Asia-Pacific’s leading multidisciplinary journal addressing issues related to alcohol and drug-related problems. Publication was increased to 7 issues annually as of 2018, the Drug and Alcohol Review presents original research, policy development and information in the drug and alcohol research field. The journal is an international forum for the views, expertise and experience of all those involved in the study of treatment of alcohol, tobacco and drug problems. The journal represents an important source of information to clinicians, drug and alcohol agency staff, researchers, policy makers, and alcohol service administrators.

Please consider this when writing your abstract, structure it accordingly (including any relevant data) and proofread abstracts carefully to avoid errors before submission.


Abstract Mentor Program

The goal of the APSAD Conference Abstract Mentor Program is to provide an opportunity for First Peoples (Aboriginal, Torres Strait Islander and Māori), Community Groups, Consumers and Early Career Researchers to have their draft abstracts mentored by more experienced authors before submitting their abstract to the conference.

Abstracts submitted by authors that have volunteered to be a mentor in the program will not automatically be accepted. The same applies for abstracts submitted by authors that were mentored by the program.

For more information please check the abstract mentor program section.